AWA
DMTK

Authentikos Wealth Advisory’s DermTech, Inc. Common Stock DMTK Stock Holding History

Authentikos Wealth Advisory’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21
Closed -$30 – 641
2023
Q3 		$30 Buy
+21
New +$53 ﹤0.01% 644

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Authentikos Wealth Advisory's DMTK Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 21 shares — an estimated $30 sold.

Authentikos Wealth Advisory first reported a position in DMTK in Q3 2023 and held it in 1 quarter. The position peaked at $30 in Q3 2023. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 21 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $30.
  • Authentikos Wealth Advisory first reported a position in DermTech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's DermTech, Inc. Common Stock position peaked at $30 in Q3 2023.
  • 77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.